Salivary Gland Infection Global Market Report 2025

Global Salivary Gland Infection Market Report 2025

Salivary Gland Infection Global Market Report 2025 - By Diagnosis (Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses), By Treatment (Medications, Surgery, Aspiration, Home Care, Other Treatments), By End User (Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User) - Market Size, Trends, And Global Forecast 2025-2034

Name: Salivary Gland Infection Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Salivary Gland Infection Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Salivary Gland Infection Global Market Report 2025

Proud Members Of

What Is Covered Under Salivary Gland Infection Market

Salivary gland infections are bacterial or viral infections that affect the salivary glands, leading to symptoms such as swelling, pain, and dry mouth. These infections occur in major glands such as the parotid, submandibular, and sublingual glands. They result from blockage, dehydration, or infections such as mumps.

The main diagnosis for the salivary gland infection are plain radiography, sialography, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide scintigraphy, high-resolution ultrasonography, and other diagnostic techniques. Plain radiography is an imaging method that utilizes X-rays to produce images of internal body structures, including salivary glands, and is used to identify stones or calcifications in the glands. Treatment options encompass medications, surgery, aspiration, home care, and other therapies. These services are provided in hospitals and clinics, medical research centres, academic institutions, and other end-user settings.

How Is The Salivary Gland Infection Market Segmented?

The salivary gland infection market covered in this report is segmented –

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

Salivary Gland Infection Market Size and growth rate 2025 to 2029: Graph

What Is The Salivary Gland Infection Market Size 2025 And Growth Rate?

The salivary gland infection market size has grown strongly in recent years. It will grow from $4.12 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in oral health issues, increase in awareness of salivary disorders, growth in prevalence of bacterial and viral infections, expanding healthcare infrastructure, rise in geriatric population, and rise in adoption of minimally invasive treatments.

What Is The Salivary Gland Infection Market Growth Forecast?

The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising awareness about oral health, growing adoption of minimally invasive procedures, increasing prevalence of chronic conditions, improvements in healthcare infrastructure, and expansion of patient access to specialized care. Major trends in the forecast period include adoption of minimally invasive procedures, advancements in sialendoscopy techniques, advanced imaging technologies, biocompatible stent developments, adoption of robotic-assisted surgeries, adoption of targeted antimicrobial therapies, and AI-driven diagnostic tools.

Book your 30 minutes free consultation with our research experts

What Is Driving The Salivary Gland Infection Market: Impact Of Rising Oral Health Issues On Infection Rates

The rise in oral health issues is expected to drive the growth of salivary gland infections market going forward. Oral health issues include conditions such as tooth decay, gum infections, and other mouth-related problems. Poor oral hygiene, unhealthy eating habits, and inadequate dental care access are driving the rise in oral health problems. The rise in oral health issues increases the risk of salivary gland infections by promoting bacterial growth and blockages in the salivary ducts. For instance, in May 2024, according to the National Health Service (NHS), a UK-based government agency, in 2022-23, 32.5 million dental treatments were provided, reflecting a 23.2% increase compared to the previous year. Therefore, the rise in oral health issues is driving the growth of the salivary gland infections market.

Who Are The Major Players In The Global Salivary Gland Infection Market?

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.

What Are The Key Trends Of The Global Salivary Gland Infection Market: Advancing Treatment With Minimally Invasive Innovations

Major companies operating in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to improve treatment outcomes, accelerate patient recovery, and enhance overall healthcare efficiency. Minimally invasive procedures involve smaller incisions and specialized tools, causing less tissue damage and promoting faster recovery. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, launched the Amrita Centre for minimally invasive salivary gland surgery, offering a groundbreaking treatment for salivary disorders through sialendoscopy, minimizing the need for surgery and preserving glandular function. The launch was highlighted by a two-day workshop showcasing expert demonstrations.

What Are Latest Mergers And Acquisitions In The Salivary Gland Infection Market: Navamedic ASA Expands Portfolio With Acquisition Of Clindamycin Rights From ACS Dobfar

In November 2022, Navamedic ASA, a Norway-based pharmaceutical company, acquired the rights and marketing authorizations for clindamycin ready-to-administer bags from ACS Dobfar for an undisclosed amount. The acquisition benefits Navamedic by expanding its product portfolio, boosting revenue, and strengthening its market position in the Nordic region. ACS Dobfar is an Italy-based pharmaceutical company that develops clindamycin, used to treat salivary gland infections.

What Is The Regional Outlook For The Global Salivary Gland Infection Market?

North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the salivary gland infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Salivary Gland Infection Market?

The salivary gland infections market consists of revenues earned by entities by providing services such as ultrasound, rehabilitation therapy, and glandular duct dilation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The salivary gland infections market includes sales of antibiotics, antiviral drugs, anti-inflammatory medications, and biocompatible stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Salivary Gland Infection Industry?

The salivary gland infections market research report is one of a series of new reports from The Business Research Company that provides salivary gland infection market statistics, including the salivary gland infection industry's global market size, regional shares, competitors with a salivary gland infection market share, detailed salivary gland infection market segments, market trends and opportunities, and any further data you may need to thrive in the salivary gland infection industry. This salivary gland infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Salivary Gland Infection Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.46 billion
Revenue Forecast In 2034	$6.09 billion
Growth Rate	CAGR of 8.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The salivary gland infection market covered in this report is segmented – 1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses 2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments 3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User Subsegments: 1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray 2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS) 3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT 4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI) 5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography) 6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography 7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Salivary Gland Infection Market Characteristics

3. Salivary Gland Infection Market Trends And Strategies

4. Salivary Gland Infection Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Salivary Gland Infection Growth Analysis And Strategic Analysis Framework

5.1. Global Salivary Gland Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Salivary Gland Infection Market Growth Rate Analysis

5.4. Global Salivary Gland Infection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Salivary Gland Infection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Salivary Gland Infection Total Addressable Market (TAM)

6. Salivary Gland Infection Market Segmentation

6.1. Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plain Radiography

Sialography

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Radionuclide Scintigraphy

High-resolution Ultrasonography

Others Diagnosis

6.2. Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Surgery

Aspiration

Home Care

Other Treatments

6.3. Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Medical Research Centers

Academic Institutes

Other End User

6.4. Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

X-ray Of Salivary Glands

Sialography With X-ray

6.5. Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Sialography

Digital Subtraction Sialography (DSS)

6.6. Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-contrast CT

Contrast-enhanced CT

6.7. Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

MRI without contrast

MRI With contrast (Dynamic MRI)

6.8. Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Planar Scintigraphy

SPECT (Single Photon Emission Computed Tomography)

6.9. Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Ultrasonography

Doppler Ultrasonography

6.10. Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fine Needle Aspiration (FNA) Biopsy

Endoscopy

Salivary Flow Test

7. Salivary Gland Infection Market Regional And Country Analysis

7.1. Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Salivary Gland Infection Market

8.1. Asia-Pacific Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Salivary Gland Infection Market

9.1. China Salivary Gland Infection Market Overview

9.2. China Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Salivary Gland Infection Market

10.1. India Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Salivary Gland Infection Market

11.1. Japan Salivary Gland Infection Market Overview

11.2. Japan Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Salivary Gland Infection Market

12.1. Australia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Salivary Gland Infection Market

13.1. Indonesia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Salivary Gland Infection Market

14.1. South Korea Salivary Gland Infection Market Overview

14.2. South Korea Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Salivary Gland Infection Market

15.1. Western Europe Salivary Gland Infection Market Overview

15.2. Western Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Salivary Gland Infection Market

16.1. UK Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Salivary Gland Infection Market

17.1. Germany Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Salivary Gland Infection Market

18.1. France Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Salivary Gland Infection Market

19.1. Italy Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Salivary Gland Infection Market

20.1. Spain Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Salivary Gland Infection Market

21.1. Eastern Europe Salivary Gland Infection Market Overview

21.2. Eastern Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Salivary Gland Infection Market

22.1. Russia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Salivary Gland Infection Market

23.1. North America Salivary Gland Infection Market Overview

23.2. North America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Salivary Gland Infection Market

24.1. USA Salivary Gland Infection Market Overview

24.2. USA Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Salivary Gland Infection Market

25.1. Canada Salivary Gland Infection Market Overview

25.2. Canada Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Salivary Gland Infection Market

26.1. South America Salivary Gland Infection Market Overview

26.2. South America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Salivary Gland Infection Market

27.1. Brazil Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Salivary Gland Infection Market

28.1. Middle East Salivary Gland Infection Market Overview

28.2. Middle East Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Salivary Gland Infection Market

29.1. Africa Salivary Gland Infection Market Overview

29.2. Africa Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Salivary Gland Infection Market Competitive Landscape And Company Profiles

30.1. Salivary Gland Infection Market Competitive Landscape

30.2. Salivary Gland Infection Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Salivary Gland Infection Market Other Major And Innovative Companies

31.1. AstraZeneca plc

31.2. Novartis AG

31.3. GSK plc

31.4. Eli Lilly and Company

31.5. Gilead Sciences, Inc.

31.6. Amgen Inc.

31.7. FUJIFILM Holdings Corporation

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Boehringer Ingelheim GmbH

31.10. Astellas Pharma Inc.

31.11. Sandoz International GmbH

31.12. Vertex Pharmaceuticals Incorporated

31.13. Incyte Corporation.

31.14. Hikma Pharmaceuticals PLC

31.15. Lupin Pharmaceuticals, Inc.

32. Global Salivary Gland Infection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Salivary Gland Infection Market

34. Recent Developments In The Salivary Gland Infection Market

35. Salivary Gland Infection Market High Potential Countries, Segments and Strategies

35.1 Salivary Gland Infection Market In 2029 - Countries Offering Most New Opportunities

35.2 Salivary Gland Infection Market In 2029 - Segments Offering Most New Opportunities

35.3 Salivary Gland Infection Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: Johnson & Johnson Financial Performance

Table 83: Roche Holding AG Financial Performance

Table 84: Merck & Co. Inc. Financial Performance

Table 85: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Johnson & Johnson Financial Performance

Figure 83: Roche Holding AG Financial Performance

Figure 84: Merck & Co. Inc. Financial Performance

Figure 85: AbbVie Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Hospital-Acquired Infection Control Global Market Report 2025 – By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products), By Technology (Phenotypic Methods, Genotypic Methods), By Diseases (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases), By Application (Disease Testing, Drug-Resistance Testing), By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

High Level Disinfection Services Global Market Report 2025 – By Services( In House, Outsource), By Compound( Formaldehyde, Glutaraldehyde, Ortho-Phthalaldehyde, Hydrogen Peroxide, Peracetic Acid, Other Components), By End-User( Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

UV Disinfection Equipment Global Market Report 2025 – By Component( UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating( Low, Medium, High ), By Application( Water Treatment, Waste Water Treatment, Air Treatment, Food and Beverage Disinfection, Surface Disinfection ), By End User( Residential, Commercial, Industrial, Municipal ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2025 – By Medication (Monotherapy, Combination Therapy ), By Drug Class (Aminoglycoside, Cephalosporin, Carbapenem, Monobactum, Other Drug Classes), By Route Of Administration (Nasal, Oral, Intravenous ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Infection Control Global Market Report 2025 – By Type (Disinfectors, Sterilization, Equipment, Consumables And Accessories, Services), By Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), By Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Other Applications), By End User (Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Infection Control Supplies Global Market Report 2025 – By Product Type (Disinfectant, Medical Face Mask, Surgical Cap, Surgical Gown, Medical Gloves), By Distribution Channel (Wholesalers, Retailers, Pharmacies, E-Commerce, Other Channels), By End-Use (Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Research Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Urinary Tract Infection Treatment Global Market Report 2025 – By Drug Class (Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nitrofurantoin), By Indication (Complicated UTI, Uncomplicated UTI), By Distribution Channel (Hospital Pharmacies, Gynecology And Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Store) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Invasive Fungal Infections Global Market Report 2025 – By Disease Type (Candidaemi And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type), By Drug Type (Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Salivary Gland Infection market?

How will the Salivary Gland Infection market drivers and restraints affect the market dynamics? What forces will shape the Salivary Gland Infection industry going forward?

The Salivary Gland Infection market major growth driver - Impact Of Rising Oral Health Issues On Infection Rates. For further insights on the Salivary Gland Infection market, request a sample here

What is the forecast market size or the forecast market value of the Salivary Gland Infection market?

The Salivary Gland Infection market size has grown strongly in recent years. The salivary gland infection market size has grown strongly in recent years. It will grow from $4.12 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in oral health issues, increase in awareness of salivary disorders, growth in prevalence of bacterial and viral infections, expanding healthcare infrastructure, rise in geriatric population, and rise in adoption of minimally invasive treatments. The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising awareness about oral health, growing adoption of minimally invasive procedures, increasing prevalence of chronic conditions, improvements in healthcare infrastructure, and expansion of patient access to specialized care. Major trends in the forecast period include adoption of minimally invasive procedures, advancements in sialendoscopy techniques, advanced imaging technologies, biocompatible stent developments, adoption of robotic-assisted surgeries, adoption of targeted antimicrobial therapies, and AI-driven diagnostic tools. For further insights on the Salivary Gland Infection market, request a sample here

How is the Salivary Gland Infection market segmented?

The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test For further insights on the Salivary Gland Infection market, request a sample here

Which region has the largest share of the Salivary Gland Infection market? What are the other regions covered in the report?

Who are the major players in the Salivary Gland Infection market?

What are the key trends in the Salivary Gland Infection market?

Major trends in the Salivary Gland Infection market include Advancing Treatment With Minimally Invasive Innovations. For further insights on the Salivary Gland Infection market, request a sample here.

What are the major opportunities in the Salivary Gland Infection market? What are the strategies for the Salivary Gland Infection market?

For detailed insights on the major opportunities and strategies in the Salivary Gland Infection market, request a sample here.

How does the Salivary Gland Infection market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Salivary Gland Infection market growth and SWOT analysis of the Salivary Gland Infection industry, request a sample here.

For detailed insights on Salivary Gland Infection's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Salivary Gland Infection industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Salivary Gland Infection industry,

What are the key dynamics influencing the Salivary Gland Infection market growth? SWOT analysis of the Salivary Gland Infection market. request a sample here.